Pfizer Announces Licensing Agreement for Its Potential Coronavirus Antiviral Pill
Pfizer on Tuesday announced an agreement allowing other companies to make its potential coronavirus antiviral pill in poorer countries and sell them royalty free. The move advances what Pfizer describes as its "comprehensive strategy to work toward equitable access to COVID-19 vaccines and treatments for all people, particularly those living in the poorest parts of the world." Hannah Bleau Breitbart http://www.breitbart.com/
Comments
Post a Comment